Increasing the Dose of Recombinant Human Thrombopoietin Can Enhance Platelet Engraftment After Allogeneic Haematopoietic Stem Cell Transplantation: A NICHE Cohort Study

Overview

Journal Br J Haematol

Specialty Hematology

Date 2024 Dec 16

PMID 39676311

Authors

Dan Feng

Qingzhen Liu

Hongye Gao

Yigeng Cao

Xin Chen

Rongli Zhang

Weihua Zhai

Donglin Yang

Jialin Wei

Yi He

Aiming Pang

Sizhou Feng

Mingzhe Han

Qiaoling Ma

Erlie Jiang

Affiliations

Soon will be listed here.

References

Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M . Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001; 98(12):3241-8. DOI: 10.1182/blood.v98.12.3241. View

Wang H, Huang M, Zhao Y, Qi J, Chen C, Tang Y . Recombinant Human Thrombopoietin Promotes Platelet Engraftment and Improves Prognosis of Patients with Myelodysplastic Syndromes and Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2017; 23(10):1678-1684. DOI: 10.1016/j.bbmt.2017.06.010. View

Kuter D . New thrombopoietic growth factors. Blood. 2007; 109(11):4607-16. PMC: 1885525. DOI: 10.1182/blood-2006-10-019315. View

Zheng X, Zhang H, Guo W, Cao Y, Liu X, Zhai W . Herombopag promotes platelet engraftment and decreases platelet transfusion after allogeneic hematopoietic stem cell transplantation. Eur J Haematol. 2023; 110(5):527-533. DOI: 10.1111/ejh.13925. View

Fu H, Zhang X, Xu L, Liu K, Huang X . Characterization of thrombopoietin kinetics within 60 days after allogeneic hematopoietic stem cell transplantation and its correlation with megakaryocyte ploidy distribution. Clin Transplant. 2015; 30(2):170-8. DOI: 10.1111/ctr.12673. View

Fu A, Peng Y, Cheng P, Wu J, Zhu X, Yang Y . Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide. Transplant Cell Ther. 2024; 30(5):500-509. DOI: 10.1016/j.jtct.2024.02.023. View

Shimazaki C, Inaba T, Uchiyama H, Sumikuma T, Kikuta T, Hirai H . Serum thrombopoietin levels in patients undergoing autologous peripheral blood stem cell transplantation. Bone Marrow Transplant. 1997; 19(8):771-5. DOI: 10.1038/sj.bmt.1700747. View

Akahoshi Y, Kimura S, Gomyo A, Hayakawa J, Tamaki M, Harada N . Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome. Hematol Oncol. 2017; 36(1):276-284. DOI: 10.1002/hon.2427. View

Yamazaki R, Kuwana M, Mori T, Okazaki Y, Kawakami Y, Ikeda Y . Prolonged thrombocytopenia after allogeneic hematopoietic stem cell transplantation: associations with impaired platelet production and increased platelet turnover. Bone Marrow Transplant. 2006; 38(5):377-84. DOI: 10.1038/sj.bmt.1705444. View

10.

Han T, Xu L, Liu D, Liu K, Wang F, Wang Y . Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial. Ann Hematol. 2014; 94(1):117-28. DOI: 10.1007/s00277-014-2158-1. View

11.

Nash R, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D . A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2000; 6(1):25-34. DOI: 10.1016/s1083-8791(00)70049-8. View

12.

Wen B, Zhang X, Chen S, Fan J, Yang S, Cai Y . Oral eltrombopag versus subcutaneous recombinant human thrombopoietin for promoting platelet engraftment after allogeneic stem cell transplantation: A prospective, non-inferiority, randomized controlled trial. Hematol Oncol. 2022; 40(4):777-786. PMC: 9790607. DOI: 10.1002/hon.3017. View